Improving Motivation and Treatment Uptake Behaviors of Patients with Eating Disorders using Patient Narrative Videos

Improving Motivation and Treatment Uptake Behaviors of Patients with Eating Disorders using Patient Narrative Videos - IMPROV-ED

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00033709

Enrollment

100

Registered

2024-02-21

Start date

2024-02-22

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F50.0 F50.1 F50.2 F50.3 F50.8

Interventions

Group 1: A parallel 4-arm pilot randomized controlled trial (RCT) approach will be used to evaluate the efficacy of three patient narrative videos. Patients will be randomized into one of four groups

Eligibility

Sex/Gender

Female

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: - Full syndrome or subclinical eating disorder according to DSM-5 (diagnosed by a trained clinician) - Written informed consent

Exclusion criteria

Exclusion criteria: - acute suicidality - psychotic disorders (lifetime) - current moderate-severe substance use disorders - currently receiving eatimg disorder treatment(s)

Design outcomes

Primary

Measure	Time frame
Main outcome measures of this study will be changes in patients’ treatment motivation and treatment uptake behaviors. Changes in treatment motivation will be measured by comparing patients’ baseline (T0) readiness for change scores (as measured by the URICA-S Questionnaire) to scores immediately after viewing the videos (T1), at one-week (T2) and three months follow-up (T3). Changes in treatment uptake will be measured by comparing the amount of treatment seeking activities indicated at baseline (T0), at one-week (T2) and three months follow-up (T3).	—

Measure

Time frame

Main outcome measures of this study will be changes in patients’ treatment motivation and treatment uptake behaviors. Changes in treatment motivation will be measured by comparing patients’ baseline (T0) readiness for change scores (as measured by the URICA-S Questionnaire) to scores immediately after viewing the videos (T1), at one-week (T2) and three months follow-up (T3). Changes in treatment uptake will be measured by comparing the amount of treatment seeking activities indicated at baseline (T0), at one-week (T2) and three months follow-up (T3).

—

Secondary

Measure	Time frame
Additional outcome measures will include changes in eating disorder psychopathology, as measured by changes in the scores of the EDE-Q Questionnaire, and changes in patients’ hopefulness and confidence for their own recovery, as measured by increased values in two visual analogue scales immediately after viewing the videos (T1) at one-week (T2) and three months follow-up (T3). The suitability of the narrative videos will be determined through a post-intervention questionnaire and qualitative interviews at T1, in which patients will be asked their views on the authenticity, empathy, and likeability of the person featured in the video, as well at the usefulness of the video(s) as a whole.	—

Measure

Time frame

Additional outcome measures will include changes in eating disorder psychopathology, as measured by changes in the scores of the EDE-Q Questionnaire, and changes in patients’ hopefulness and confidence for their own recovery, as measured by increased values in two visual analogue scales immediately after viewing the videos (T1) at one-week (T2) and three months follow-up (T3). The suitability of the narrative videos will be determined through a post-intervention questionnaire and qualitative interviews at T1, in which patients will be asked their views on the authenticity, empathy, and likeability of the person featured in the video, as well at the usefulness of the video(s) as a whole.

—

Countries

Germany

Contacts

Public ContactMelissa-Claire Daugelat

Psychosomatische Medizin und Psychotherapie

melissa-claire.daugelat@med.uni-tuebingen.de+497071 29 86735

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026